Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen–SAHA hybrids and related species
Chemotherapeutic agents combining several active groups within a single molecule can modulate multiple cellular pathways and, thus, exhibit higher efficacy than single-target drugs. In this study, six new hybrid compounds combining tamoxifen (TAM) or ferrocifen (FcTAM) structural motifs with suberoylanilide hydroxamic acid (SAHA) were synthesised and evaluated. Antiproliferative activity was first explored in cancer cell lines. Combining FcTAM and SAHA structural motifs to form the unprecedented FcTAMâSAHA hybrid molecule led to an increased cytotoxicity (IC50 = 0.7 μM) in triple-negative MDA-MB-231 breast cancer cells when compared to FcTAM or SAHA alone (IC50 = 2.6 μM and 3.6 μM, respectively), while the organic hybrid analogue TAMâSAHA was far less cytotoxic (IC50 = 8.6 μM). In hormone-dependent MCF-7 breast cancer cells, FcTAMâSAHA was more active (IC50 = 2.0 μM) than FcTAM (IC50 = 4.4 μM) and TAMâSAHA (IC50 > 10 μM), but less toxic than SAHA (IC50 = 1.0 μM). Surprisingly, FcTAMâPSA, an N1-phenylsuberamide derivative, also possessed strong antiproliferative activity (IC50 = 0.5 μM and 1.8 μM in MDA-MB-231 and MCF-7 cells, respectively). Subsequent biochemical studies indicate that estrogen receptor alpha (ERα) and histone deacetylases (HDAC) are not the main targets of the hybrid compounds for their antiproliferative effect. Interestingly, both organometallic compounds were able to induce p21waf1/cip1 gene expression in MCF-7 breast cancer cells in accordance with their antiproliferative activity.
Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles
作者:Eleonora Colombo、Davide Andrea Coppini、Simone Maculan、Pierfausto Seneci、Benedetta Santini、Filippo Testa、Lucia Salvioni、Giovanni Maria Vanacore、Miriam Colombo、Daniele Passarella
DOI:10.1039/d2ra06306a
日期:——
Hetero-nanoparticles self-assembled from a conjugate bearing folicacid as the targeting agent, and another bearing paclitaxel as the active agent are reported. Hetero-nanoparticles containing varying percentages of folicacid conjugates are characterised, and their biological activity is determined.
Design and synthesis of (Z)-1,2-diphenyl-1-(4-methanesulfonamidophenyl)alk-1-enes and (Z)-1-(4-azidophenyl)-1,2-diphenylalk-1-enes: novel inhibitors of cyclooxygenase-2 (COX-2) with anti-inflammatory and analgesic activity
作者:Md. Jashim Uddin、P.N. Praveen Rao、Edward E. Knaus
DOI:10.1016/j.bmc.2004.10.017
日期:2005.1
A group of novel (Z)-1,2-diphenyl-1-9(4-methanesulfonamidophenyl)alk-1-enes was designed for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. In vitro COX-1/COX-2 enzyme inhibition studies identified (Z)-1,2-dipheny1-1-(4-methanesulfonamidophenyl)oct-1-ene(8d) as a highly potent (IC50=0.03 muM), and an extremely selective [COX-2 SI (selectivity index)> 3,333], COX-2 inhibitor that showed good anti-inflammatory (AI) activity (ID50 = 2.8 mg/kg). A molecular modeling (docking) study showed that the p-MeSO2NH group present in (Z)-8d inserts deep inside the 2degrees-pocket of the COX-2 binding site, it undergoes a hydrophobic interaction with Ala(516) and Gly(519), and one of the O-atoms of the MeSO2 group participates in a weak hydrogen bonding interaction with the NH2 of Arg(513) (distance = 3.85 Angstrom). Similar in vitro COX-1/COX-2 enzyme inhibition studies showed that the azido compound 1-(4-azidophenyl)-1,2-diphenyloct-1-ene (9c) is also a potent and selective COX-2 inhibitor (COX-2 IC50 = 0.11 muM: SI > 909) that exhibits good AI activity (ID50 = 5.0 mg/kg). A docking experiment to determine the orientation of (Z)-9c within the COX-2 binding site showed that the linear p-N-3 group inserts into the COX-2 2degrees-pocket, where it undergoes an ion-ion (electrostatic) interaction with Arg(513). Structure-activity data acquired indicate that an olefin having either a C-1 p-MeSO2NH-phenyl, or a p-N-3-phenyl, substituent, that is, cis to a C-2 unsubstituted phenyl substituent, in conjunction with C-1 unsubstituted phenyl and C-2 alkyl substituents, provides a novel template to design acyclic olefinic COX-2 inhibitors. (C) 2004 Elsevier Ltd. All rights reserved.
The replacement of a phenol group by an aniline or acetanilide group enhances the cytotoxicity of 2-ferrocenyl-1,1-diphenyl-but-l-ene compounds against breast cancer cells
We have previously shown that conjugated ferrocenyl p-phenols show strong cytotoxic effects against both the hormone-dependent MCF-7 and hormone-independent MDA-MB-231 breast cancer cell lines, possibly via oxidativequinonemethideformation. We now present a series of analogous amine and acetamide compounds: 2-ferrocenyl-1-(4-aminophenyl)-1-phenyl-but-1-ene (Z+E-2), 2-ferrocenyl-1-(4-N-acetylami
先前我们已经证明,共轭二茂铁基对苯酚可能通过氧化醌甲基化物形成,对激素依赖性MCF-7和激素依赖性MDA-MB-231乳腺癌细胞系均表现出强大的细胞毒性作用。现在我们介绍一系列类似的胺和乙酰胺化合物:2-二茂铁基-1-(4-氨基苯基)-1-苯基-丁-1-烯(Z + E - 2),2-二茂铁基-1-(4- N-乙酰氨基苯基)-1-苯基丁-1-烯(Z - 3)及其相应的有机分子1-(4-氨基苯基)-1,2-双苯基丁-1-烯(Z + E - 4)和1-(4- ñ-乙酰氨基苯基)-1,2-双苯基丁-1-烯(Z + E - 5)。所有的化合物对雌激素受体具有足够的相对结合亲和力值。在计算机ER对接实验中,ERα介于2.8%和5.7%之间,ERβ介于0.18%和15.5%之间,以及放热配体结合。化合物2和3对MCF-7细胞系具有双重雌激素/细胞毒活性;它们在低浓度(0.1μM)时具有增生作用,在高浓度
Self-assembled 4-(1,2-diphenylbut-1-en-1-yl)aniline based nanoparticles: podophyllotoxin and aloin as building blocks
作者:Gaia Fumagalli、Michael S. Christodoulou、Benedetta Riva、Inigo Revuelta、Cristina Marucci、Veronica Collico、Davide Prosperi、Sergio Riva、Dario Perdicchia、Ivan Bassanini、Aida García-Argáez、Lisa Dalla Via、Daniele Passarella
DOI:10.1039/c6ob02591a
日期:——
The ability of 4-(1,2-diphenylbut-1-en-1-yl)aniline as a self-assembly inducer is reported.